Close Menu

Breaking News

A new microbiome analysis uncovered cancer type-specific bacterial community features, along with intracellular bacteria in tumor and associated immune cells.

The investment bank gave shares of the Temple City, California-based genetic testing company a buy rating and a $20 price target.

The deal will join Tangen's GeneSpark point-of-care instrument with LabWare's portable disease surveillance kit for SARS-CoV-2.

The company said that a large portion of the offering's proceeds would be used to end criminal and civil investigations over its past billing practices.

The test uses a proprietary at-home PCR nasal swab test with a turnaround time of 24 hours and is authorized for use by at-risk people.

The company is also working on a diagnostic COVID-19 test, called LamPore, that will run on its MinIon and GridIon nanopore sequencing platforms

Independent research teams have tackled the genetic history of the Levant, Anatolia, and other parts of the Near East to retrace population movement and mixing since the Bronze Age.

The findings suggested recovered patients could still be viral carriers and might benefit from further monitoring after their release from the hospital.

The company said that by the end of June it would have made available more than 500,000 kits, which allow individuals to self-collect nasal samples at home.

Including the new round, the maker of software to support precision oncology care and drug discovery has landed nearly $100 million in equity investments to date. 

More than 70 percent of labs surveyed experienced supply chain interruptions, forcing them to validate three or more diagnostic testing methods.

Ginkgo said that next-generation sequencing, coupled with its automation capabilities, has the potential to increase COVID-19 testing capacity.

The reference panel is an independent performance validation step for SARS-CoV-2 tests that are being used for clinical, not research, purposes.

The study will compare whole-genome sequencing and RNA sequencing to conventional diagnostic methods in about 450 acute leukemia patients in Sweden.

The researchers noted that using Korea1K as a reference resulted in better imputation accuracy for Koreans than the 1000 Genomes dataset.

The collection of more than 125,000 exomes and 15,000 genomes has enabled an analysis of loss-of-function variants, may help diagnose rare disease, and guide drug development.

Researchers mapped and characterized rare structural variants in whole-genome sequence data for almost 18,000 individuals for future disease and trait studies.

The funding marks the second cycle of CZI's Essential Open Source Software program, which awards between $50,000 and $250,000 in total costs per project.

JTCC will adapt validated tests developed by GTC for DNA and RNA profiling of all cancers in its patients with solid tumors of blood cancers.

The tests will run on Bosch's automated Vivalytic platform, with BioGX developing, manufacturing, and supplying reagents for the cartridges.

The test kit is designed to detect regions of the virus' nucleocapsid and envelope genes in upper respiratory specimens and bronchoalveolar lavage.

Genos customers have until June 22 to dowload their exome and variant data from the Genos portal before it will no longer be accessible.

Single-cell RNA sequencing uncovered interactions between colorectal cancer alterations and corresponding immune cell and stromal features.

With data on almost 250 individuals, researchers saw shifting hunter-gatherer, Anatolian farmer, and Pontic steppe ancestry in French populations going back thousands of years.

Pages

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.